SCHEMBL3211262

SCHEMBL3211262

CCN(CC)c1cc[c]c(OCOC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.36
ALDH1A1 P00352 7/20 0.36
L3MBTL1 Q9Y468 5/20 0.36
CYP3A4 P08684 2/20 0.35
TERT O14746 1/20 0.35
S100B P04271 1/20 0.34
MAPT P10636 3/20 0.32
MAPK1 P28482 3/20 0.32
PSMD14 O00487 1/20 0.32
TSHR P16473 1/20 0.32
RECQL P46063 1/20 0.32
GFER P55789 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GLA P06280 1/20 0.30
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10748336 0.85 ALDH1A1 (0.38) ALDH1A1L3MBTL1CYP3A4TERTS100B
SCHEMBL15475170 0.83 CALM1 (0.30)
SCHEMBL8128063 0.83 ALDH1A1 (0.42) ALDH1A1L3MBTL1CYP3A4TERTS100B
SCHEMBL11644369 0.81 ALDH1A1 (0.35) ALDH1A1L3MBTL1CYP3A4TERTS100B
SCHEMBL15474902 0.79 ALDH1A1 (0.38) ALDH1A1L3MBTL1CYP3A4TERTS100B
SCHEMBL15474497 0.77 NOX1 (0.44) BACE1ALDH1A1L3MBTL1CYP3A4MAPT
SCHEMBL22689697 0.77 ALDH1A1 (0.33) ALDH1A1L3MBTL1CYP3A4TERTS100B
SCHEMBL15475124 0.77 APP (0.42) ALDH1A1L3MBTL1TDP1NPC1RAB9A
SCHEMBL28130967 0.76 PTPN1 (0.31)
SCHEMBL15474772 0.76 BACE1 (0.42) BACE1ALDH1A1L3MBTL1CYP3A4TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101558038-B Curcumin derivative TOKYO INST TECH 2013-05-01 CN claimed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US claimed
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
CN-101558038-B Curcumin derivative TOKYO INST TECH 2013-05-01 CN disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
CN-101558038-A Novel curcumin derivative TOKYO INST TECH (JP) 2009-10-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 BACE1 1/4885ALDH1A1 253/4885L3MBTL1 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.